LEXINGTON, Ky. (Sept 20, 2013) -- The Center for Clinical and Translational Science (CCTS) is now accepting applications for drug discovery and development projects for potential partnerships with the National Insitutes of Health (NIH).
Linda Dwoskin, endowed professor in pharmaceutical education at the UK College of Pharmacy, serves as director of the Drug Discovery and Development Core of the CCTS. Jon Thorson, professor of pharmaceutical sciences at the UK College of Pharmacy and director of the Center for Pharmaceutical Research and Innovation, serves as co-director of the CCTS Core.
As a result of interactions with the National Center for Advancing Translational Sciences (NCATS) and the National Cancer Institute (NCI), UK drug discovery/development investigators will have the potential opportunity to engage NIH scientists and infrastructure to advance specific translational objectives. The function of this exercise is to identify projects suitable for NIH partnership and facilitate the engagement by NIH.
This is not a funding mechanism, but an opportunity to advance preclinical or clinical translational discovery and development related to a given project at no cost to the investigator. A list and descriptions of available services from the NCI and NCATS is available at http://next.cancer.gov/pipelineManagement/stageGate.htm.
To take advantage of one or more of the available services, provide a brief description (one page maximum including up to five citations, 11 point font, 0.5 inch margins) that specifically articulates the significance and translational potential of your project, the specific stage of your project, the specific NIH services desired and how engagement by NIH could advance the translational potential of the project. All prospective applicants must submit their materials to Charolette Garland at 257-5265, email@example.com by Oct. 10.
The Therapeutic Advisory Panel (TAP) will review the application materials by Oct. 24 and prioritize the list of applications. In early November, TAP will nominate up to five projects for further consideration by the NIH institutes as potential collaborative partnerships. Applicants will be notified of the application status after TAP review and, for those selected for NIH nomination, following the preliminary review.
MEDIA CONTACT: Mallory Powell, firstname.lastname@example.org or 859-323-2395